Brief: J B Chemicals And Pharmaceuticals Enters Into An Agreement With Glenmark Pharmaceuticals To Acquire 'Razel' Franchise
Dec 14 (Reuters) - Glenmark Pharmaceuticals Ltd
GLEN.NS :
* ENTERED INTO AN AGREEMENT WITH GLENMARK PHARMACEUTICALS
LTD TO
ACQUIRE 'RAZEL' FRANCHISE
* COST OF ACQUISITION AT 3.14 BILLION RUPEES
* ACQUISITION OF RAZEL FRANCHISE FOR INDIA AND NEPAL
Source text for Eikon: ID:nBSE7HsBl1
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on J B Chemicals and Pharmaceuticals
See all newsIndian drugmaker Torrent Pharma posts lower quarterly profit on acquisition costs
India's J B Chemicals and Pharmaceuticals drops after quarterly profit fall
Brief: JB Chemicals Posts March-Qtr Consol Net PAT 1.01 Billion Rupees
Morgan Stanley initiates coverage on India's Torrent Pharma, Mankind Pharma
Brief: JB Chemicals Says Narayan Saraf Resigns As CFO